NASDAQ:OPK

OPKO Health News Headlines

$3.44
-0.29 (-7.77 %)
(As of 07/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.26
$3.52
50-Day Range
$3.44
$4.24
52-Week Range
$2.84
$6.27
Volume11.39 million shs
Average Volume4.06 million shs
Market Capitalization$2.31 billion
P/E Ratio31.28
Dividend YieldN/A
Beta1.76

OPKO Health (NASDAQ OPK) News Headlines Today

SourceHeadline
OPKO Health (NASDAQ:OPK) PT Lowered to $6.00 at Barrington ResearchOPKO Health (NASDAQ:OPK) PT Lowered to $6.00 at Barrington Research
marketbeat.com - July 30 at 12:19 PM
OPKO Health (NASDAQ:OPK) Posts  Earnings ResultsOPKO Health (NASDAQ:OPK) Posts Earnings Results
americanbankingnews.com - July 31 at 6:56 PM
OPKO Healths (OPK) Q2 Earnings Lag Estimates, Margins DownOPKO Health's (OPK) Q2 Earnings Lag Estimates, Margins Down
msn.com - July 30 at 2:12 PM
Opko Health (OPK) Q2 2021 Earnings Call TranscriptOpko Health (OPK) Q2 2021 Earnings Call Transcript
finance.yahoo.com - July 30 at 2:12 PM
OPKO Health (NASDAQ:OPK) Price Target Cut to $6.00 by Analysts at Barrington ResearchOPKO Health (NASDAQ:OPK) Price Target Cut to $6.00 by Analysts at Barrington Research
americanbankingnews.com - July 30 at 1:31 PM
Are OPKO Health, Inc.s (NASDAQ:OPK) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?Are OPKO Health, Inc.'s (NASDAQ:OPK) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
nasdaq.com - July 30 at 12:15 AM
OPKO Health (OPK) Reports Q2 Loss, Misses Revenue EstimatesOPKO Health (OPK) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - July 30 at 12:15 AM
BRIEF-Opko Health Reports 2021 Second Quarter Business Highlights And Financial ResultsBRIEF-Opko Health Reports 2021 Second Quarter Business Highlights And Financial Results
msn.com - July 29 at 7:09 PM
OPKO Health Reports 2021 Second Quarter Business Highlights and Financial ResultsOPKO Health Reports 2021 Second Quarter Business Highlights and Financial Results
finance.yahoo.com - July 29 at 7:09 PM
Opko Health earnings: heres what Wall Street expectsOpko Health earnings: here's what Wall Street expects
markets.businessinsider.com - July 27 at 1:49 PM
OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021
finance.yahoo.com - July 20 at 9:53 AM
OPKO Health, Inc. (NASDAQ:OPK) Insider Robert J. Shovlin Sells 130,604 SharesOPKO Health, Inc. (NASDAQ:OPK) Insider Robert J. Shovlin Sells 130,604 Shares
americanbankingnews.com - July 18 at 4:20 PM
First Week of March 2022 Options Trading For OPKO HealthFirst Week of March 2022 Options Trading For OPKO Health
nasdaq.com - July 16 at 2:57 PM
OPKO Health, CAMP4 Therapeutics Ink Oligonucleotide Platform With Focus On Drug-Resistant EpilepsyOPKO Health, CAMP4 Therapeutics Ink Oligonucleotide Platform With Focus On Drug-Resistant Epilepsy
finance.yahoo.com - July 12 at 5:21 PM
OPKO Health (NASDAQ:OPK) Stock Price Down 4.7%OPKO Health (NASDAQ:OPK) Stock Price Down 4.7%
americanbankingnews.com - July 12 at 2:30 PM
BRIEF-OPKO Health Licenses Oligonucleotide Therapeutics Platform To CAMP4 TherapeuticsBRIEF-OPKO Health Licenses Oligonucleotide Therapeutics Platform To CAMP4 Therapeutics
msn.com - July 12 at 12:21 PM
OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 TherapeuticsOPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics
finance.yahoo.com - July 12 at 12:21 PM
OPKO Health (OPK) and Nicoya Sign RAYALDEE DealOPKO Health (OPK) and Nicoya Sign RAYALDEE Deal
finance.yahoo.com - June 28 at 2:02 PM
Verint Extends Leadership in Workforce Management with Launch of AI-Powered Intelligent InterviewingVerint Extends Leadership in Workforce Management with Launch of AI-Powered Intelligent Interviewing
finance.yahoo.com - June 22 at 9:58 AM
OPKO Health, Nicoya Therapeutics Ink Rayaldee Pact For Hyperparathyroidism In Greater ChinaOPKO Health, Nicoya Therapeutics Ink Rayaldee Pact For Hyperparathyroidism In Greater China
finance.yahoo.com - June 21 at 6:09 PM
BRIEF-Opko Health To Develop And Commercialize Rayaldee® In Greater China With Nicoya TherapeuticsBRIEF-Opko Health To Develop And Commercialize Rayaldee® In Greater China With Nicoya Therapeutics
msn.com - June 21 at 1:08 PM
OPKO Health to Develop and Commercialize RAYALDEE(R) in Greater China with Nicoya TherapeuticsOPKO Health to Develop and Commercialize RAYALDEE(R) in Greater China with Nicoya Therapeutics
marketwatch.com - June 21 at 1:08 PM
OPKO Health (OPK) Inks Agreement to Sell Its Ireland FacilityOPKO Health (OPK) Inks Agreement to Sell Its Ireland Facility
finance.yahoo.com - June 21 at 1:08 PM
This Is Why OPKO Health, Inc.s (NASDAQ:OPK) CEO Compensation Looks AppropriateThis Is Why OPKO Health, Inc.'s (NASDAQ:OPK) CEO Compensation Looks Appropriate
finance.yahoo.com - June 19 at 10:25 AM
OPKO Health Offloads Fill and Finish Manufacturing Facility in Ireland To Horizon TherapeuticsOPKO Health Offloads Fill and Finish Manufacturing Facility in Ireland To Horizon Therapeutics
finance.yahoo.com - June 17 at 3:25 PM
BRIEF-Opko Health Announces Sale Of Its Sterile Fill And Finish Manufacturing Facility In IrelandBRIEF-Opko Health Announces Sale Of Its Sterile Fill And Finish Manufacturing Facility In Ireland
msn.com - June 17 at 9:01 AM
OPKO Health to Sell Ireland Plant to Horizon Therapeutics for $65 MillionOPKO Health to Sell Ireland Plant to Horizon Therapeutics for $65 Million
marketwatch.com - June 17 at 9:01 AM
OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in IrelandOPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland
finance.yahoo.com - June 17 at 9:01 AM
We Think OPKO Health (NASDAQ:OPK) Can Stay On Top Of Its DebtWe Think OPKO Health (NASDAQ:OPK) Can Stay On Top Of Its Debt
nasdaq.com - June 14 at 11:34 PM
Leadership Additions Announced to Support Expanding US Government and Healthcare Provider KidneyIntelX DeploymentLeadership Additions Announced to Support Expanding US Government and Healthcare Provider KidneyIntelX Deployment
markets.businessinsider.com - June 7 at 9:52 AM
July 9th Options Now Available For OPKO HealthJuly 9th Options Now Available For OPKO Health
nasdaq.com - May 28 at 8:10 PM
Why Is OPKO Health (OPK) Down 5.6% Since Last Earnings Report?Why Is OPKO Health (OPK) Down 5.6% Since Last Earnings Report?
finance.yahoo.com - May 28 at 3:10 PM
OPKO Health to Participate in the Jefferies Virtual Healthcare ConferenceOPKO Health to Participate in the Jefferies Virtual Healthcare Conference
finance.yahoo.com - May 27 at 1:18 PM
OPKO Health Reports Transfer of Licensed Rights to RAYALDEE(R) in Japan to ViforOPKO Health Reports Transfer of Licensed Rights to RAYALDEE(R) in Japan to Vifor
marketwatch.com - May 25 at 3:11 PM
How Much Of OPKO Health, Inc. (NASDAQ:OPK) Do Insiders Own?How Much Of OPKO Health, Inc. (NASDAQ:OPK) Do Insiders Own?
finance.yahoo.com - May 25 at 10:11 AM
OPKO Health Reports Transfer of Licensed Rights to RAYALDEE® in Japan to ViforOPKO Health Reports Transfer of Licensed Rights to RAYALDEE® in Japan to Vifor
finance.yahoo.com - May 24 at 8:16 AM
Cramers lightning round: Nokia had a decent quarterCramer's lightning round: Nokia had a decent quarter
msn.com - May 21 at 10:41 PM
Mitogen Activated Protein Kinase 8 Market Size Report 2021 Industry News Analysis, Upstream Raw Material Suppliers, Major Players and Product TypesMitogen Activated Protein Kinase 8 Market Size Report 2021 Industry News Analysis, Upstream Raw Material Suppliers, Major Players and Product Types
marketwatch.com - May 18 at 9:26 PM
December 2022 Options Now Available For OPKO Health (OPK)December 2022 Options Now Available For OPKO Health (OPK)
nasdaq.com - May 17 at 12:37 PM
OPKO Health Enters into Exchange Agreements with Certain 4.5% Convertible Senior NoteholdersOPKO Health Enters into Exchange Agreements with Certain 4.5% Convertible Senior Noteholders
finance.yahoo.com - May 7 at 1:46 PM
June 25th Options Now Available For OPKO HealthJune 25th Options Now Available For OPKO Health
nasdaq.com - May 6 at 12:38 PM
If You Had Bought OPKO Health (NASDAQ:OPK) Stock A Year Ago, You Could Pocket A 85% Gain TodayIf You Had Bought OPKO Health (NASDAQ:OPK) Stock A Year Ago, You Could Pocket A 85% Gain Today
nasdaq.com - April 29 at 8:55 PM
OPKO Health: Q1 Earnings InsightsOPKO Health: Q1 Earnings Insights
benzinga.com - April 28 at 11:26 PM
OPKO Health (OPK) Meets Q1 Earnings EstimatesOPKO Health (OPK) Meets Q1 Earnings Estimates
finance.yahoo.com - April 28 at 11:26 PM
Opko Health (OPK) Q1 2021 Earnings Call TranscriptOpko Health (OPK) Q1 2021 Earnings Call Transcript
finance.yahoo.com - April 28 at 11:26 PM
OPKO Health, Inc. to Host Earnings CallOPKO Health, Inc. to Host Earnings Call
finance.yahoo.com - April 28 at 6:26 PM
OPKO Health Reports 2021 First Quarter Business Highlights and Financial ResultsOPKO Health Reports 2021 First Quarter Business Highlights and Financial Results
finance.yahoo.com - April 28 at 6:26 PM
Heres what Wall Street expects from Opko Healths earningsHere's what Wall Street expects from Opko Health's earnings
markets.businessinsider.com - April 27 at 12:10 PM
Major League Soccer Renews with BioReference Laboratories as COVID-19 Testing Provider for Second YearMajor League Soccer Renews with BioReference Laboratories as COVID-19 Testing Provider for Second Year
finance.yahoo.com - April 27 at 12:10 PM
OPK Makes Bullish Cross Above Critical Moving AverageOPK Makes Bullish Cross Above Critical Moving Average
nasdaq.com - April 22 at 3:39 PM
Clinical Laboratory Test Market Size 2021 by Share, Growth, Trends, Market Dynamics and Forecast to 2024 Research Report by Absolute ReportsClinical Laboratory Test Market Size 2021 by Share, Growth, Trends, Market Dynamics and Forecast to 2024 Research Report by Absolute Reports
marketwatch.com - April 22 at 10:39 AM
This page was last updated on 8/1/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.